GW Pharmaceuticals Appoints Dr. Kenneth Sommerville As VP, Clinical Science
5/6/2014 9:58:42 AM
LONDON, May 6, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced the appointment of Kenneth Sommerville MD to the newly created position of VP, Clinical Science, based in the United States.
Help employers find you! Check out all the jobs and post your resume.
comments powered by